Darius N. Lakdawalla, PhD


Two Steps Forward, One Step Back: 50 Years of Societal Value From LDL-C–Lowering Therapies

April 13, 2021

Low-density lipoprotein cholesterol (LDL-C)–lowering therapies have yielded significant value to society through reduced costs for both fatal and nonfatal cardiovascular disease events. The vast majority of this value has accrued to patients.